Quent Capital, LLC

Position in CTXR — Citius Pharmaceuticals, Inc.

CIK 1912338 NEW YORK, NY

Position in CTXR

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,560

-$1,278 QoQ

Shares Held

4,232

-0.8% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 43 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Quent Capital, LLC holds $1,397,990 across 37 Biotechnology names. CTXR ranks #32 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	462	$229,489
2	IMMX	Immix Biopharma, Inc.	20,000	$206,200
3	REGN	Regeneron Pharmaceuticals, Inc.	312	$194,544
4	MRVI	Maravai Lifesciences Holdings, Inc.	30,000	$187,200
5	SLS	SELLAS Life Sciences Group, Inc.	7,022	$103,644
6	JAZZ	Jazz Pharmaceuticals plc	308	$74,218
7	INCY	Incyte Corp	429	$48,631
8	PTGX	Protagonist Therapeutics, Inc	337	$41,309

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,560	4,232	-0.8%	Shares	Sole	2026-08-07
2026-03-31	$3,838	4,265	+361.1%	Shares	Sole	2026-04-28
2025-12-31	$718	925	+756.5%	Shares	Sole	2026-01-29
2025-09-30	$133	108	0.0%	Shares	Sole	2025-10-27
2025-03-31	$160	108	0.0%	Shares	Sole	2025-04-04
2024-12-31	$432	108	-96.1%	Shares	Sole	2025-01-29
2024-09-30	$1,378	2,752	0.0%	Shares	Sole	2024-10-04
2024-06-30	$1,607	2,752	0.0%	Shares	Sole	2024-07-08
2024-03-31	$2,468	2,752	0.0%	Shares	Sole	2024-06-28
2023-12-31	$2,083	2,752	+3.8%	Shares	Sole	2024-06-17
2023-09-30	$1,812	2,650	+46.8%	Shares	Sole	2024-06-17
2023-06-30	$2,166	1,805	—	Shares	Sole	2024-06-17
No filing history on record for this holder in this stock.